Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Type 2 diabetes and intracellular CD59-effect on β-cell dedifferentiation
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
2022 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Type 2 diabetes is one of the biggest health problems globally. It is caused by insulin resistance and decreased β-cell mass and function due to β-cells apoptosis and dedifferentiation. A novel spliced isoforms of CD59 were discovered in human and mouse pancreatic islets. Those isoforms lack the GPI anchor and instead have unique C-terminal domains. These isoforms were named Isoforms Rescuing Insulin Secretion 1 and 2 (IRIS-1 and IRIS-2). IRIS-1 and 2 exist in the cytosol of the β-cells, where they colocalize with the insulin granules and mediate the insulin secretion via interaction with the SNARE proteins complex. Antibodies raised against those isoforms showed that islets isolated from T2D patients have a lower expression of both IRIS-1 and IRIS-2, as compared to islets isolated from healthy donors. This thesis demonstrated the electropositive path at the C-terminal domain of the IRIS-1, which is responsible for localizing this protein into the nucleus. IRIS-1 binds to histones within the nucleus and may act as a transcription factor. We also showed that IRIS-1 is required for maintaining β-cells identity and function, as cells overexpressing IRIS-1 display higher expression levels of β-cells maturation makers, such as Urocortin 3, Pdx 1, Nkx 6.1, Maf A, and Maf B. 

Place, publisher, year, edition, pages
2022. , p. 41
National Category
Immunology in the medical area Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-497312OAI: oai:DiVA.org:uu-497312DiVA, id: diva2:1739703
Subject / course
Pharmaceutical Biosciences
Educational program
Master of Science Programme in Pharmacy
Supervisors
Examiners
Available from: 2023-02-27 Created: 2023-02-27 Last updated: 2024-02-16Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Department of Pharmaceutical Biosciences
Immunology in the medical areaEndocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 54 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf